Eurofins Clinical Enterprise 175 Crossing Boulevard, Framingham, MA 01702

Eurofins Clinical Enterprise is a premier multiomic services laboratory, engineered for integration and powered for collaboration. Located in Framingham, MA, our facility is CLIA-certified, CAP-accredited, and NY CLEP-licensed, ensuring the highest standards in clinical testing and data integration.

Our advanced laboratory offers customizable data integrations and rapid, accurate testing at competitive prices. With the introduction of the NovaSeq X Plus, we provide unmatched throughput, industry-leading accuracy, and cost efficiency for high-volume research. Book your run with the NovaSeq X Plus and elevate your testing to new heights.

At Eurofins Clinical Enterprise, our unique industry-leading capacity enables us to deliver fast, precise results, propelling your research to the next phase. Benefit from our customizable real-time data exchange, which streamlines data delivery and ensures you get the data you need, when you need it.

We are committed to continuous innovation and engineering excellence, always seeking better ways to apply our testing methods to improve human health. Our flexible, high-quality next-generation sequencing capabilities allow us to rapidly sequence whole genomes, exomes, targeted regions, microbiomes, and more.

We also offer state-of-the-art genotyping arrays using the latest Illumina Infinium chips and qPCR-based testing across a variety of applications, including small- to mid-size (20–50 target) SNP panels. Our team is dedicated to providing customized testing solutions, IT integrations, logistics, and method development tailored to meet your specific needs.

With high-throughput and purpose-designed automation on advanced equipment, we deliver high-complexity lab solutions for multiple markets. Interested in partnering with a reputable reference laboratory? Download our guide to discover the five signs every researcher should look for in a trusted lab partner.

Choose Eurofins Clinical Enterprise for your next-generation sequencing and multiomic research needs, and experience the future of omics research today.